INitial Targeted Engagement for Regulatory Advice (INTERACT) meeting

INTERACT meeting on CBER/CDER Products is a meeting at a specific time early in product development.

Solutions you may be interested in

Entering the US Market

Achieve US success for all types of products, across all stages of development, leveraging regulatory strategy, FDA submission compliance, and effective partnering with the FDA.

Regulatory Strategy

Design global patient-centric regulatory strategies to ensure expedited product development leading to patient access.

Regulatory Operation & Submission

We ensure accurate, timely, and efficient regulatory preparation and submission.

Diverse team of professionals smiling, representing expert support at VCLS.

Questions? Get the answers from our expert team

No two product development paths are the same. Talk to our experts about your development challenges and we will provide you actionable recommendations.

Contact Us

INitial Targeted Engagement for Regulatory Advice (INTERACT) meeting

INitial Targeted Engagement for Regulatory Advice (INTERACT) meeting

RELATED INSIGHTS

Achieve Success for Your First US Product Application – Pathway to IND

FDA Meeting Series: How, When and What – INTERACT Meetings

Ask the Experts: How to have an effective INTERACT meeting with the FDA

Solutions you may be interested in

Entering the US Market

Regulatory Strategy​

Regulatory Operation & Submission

Questions? Get the answers from our expert team

Regulatory Strategy